Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

516 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy.
Zhou Y, Li M, Zhou K, Brown J, Tsao T, Cen X, Husman T, Bajpai A, Dunn ZS, Yang L. Zhou Y, et al. Among authors: cen x. Cancers (Basel). 2022 May 1;14(9):2266. doi: 10.3390/cancers14092266. Cancers (Basel). 2022. PMID: 35565395 Free PMC article. Review.
Interleukin 15 in Cell-Based Cancer Immunotherapy.
Zhou Y, Husman T, Cen X, Tsao T, Brown J, Bajpai A, Li M, Zhou K, Yang L. Zhou Y, et al. Among authors: cen x. Int J Mol Sci. 2022 Jun 30;23(13):7311. doi: 10.3390/ijms23137311. Int J Mol Sci. 2022. PMID: 35806311 Free PMC article. Review.
Engineering allorejection-resistant CAR-NKT cells from hematopoietic stem cells for off-the-shelf cancer immunotherapy.
Li YR, Zhou Y, Yu J, Zhu Y, Lee D, Zhu E, Li Z, Kim YJ, Zhou K, Fang Y, Lyu Z, Chen Y, Tian Y, Huang J, Cen X, Husman T, Cho JM, Hsiai T, Zhou JJ, Wang P, Puliafito BR, Larson SM, Yang L. Li YR, et al. Among authors: cen x. Mol Ther. 2024 Apr 6:S1525-0016(24)00221-1. doi: 10.1016/j.ymthe.2024.04.005. Online ahead of print. Mol Ther. 2024. PMID: 38584391 Free article.
Generation of allogeneic CAR-NKT cells from hematopoietic stem and progenitor cells using a clinically guided culture method.
Li YR, Zhou Y, Yu J, Kim YJ, Li M, Lee D, Zhou K, Chen Y, Zhu Y, Wang YC, Li Z, Yu Y, Dunn ZS, Guo W, Cen X, Husman T, Bajpai A, Kramer A, Wilson M, Fang Y, Huang J, Li S, Zhou Y, Zhang Y, Hahn Z, Zhu E, Ma F, Pan C, Lusis AJ, Zhou JJ, Seet CS, Kohn DB, Wang P, Zhou XJ, Pellegrini M, Puliafito BR, Larson SM, Yang L. Li YR, et al. Among authors: cen x. Nat Biotechnol. 2024 May 14. doi: 10.1038/s41587-024-02226-y. Online ahead of print. Nat Biotechnol. 2024. PMID: 38744947
Efficacy of chidamide maintenance therapy versus autologous stem cell transplantation versus observation as a post-remission choice in the survival of adult patients with peripheral T-cell lymphoma: Post hoc analysis of a prospective, multicenter, phase 2 study in China.
Wang W, Zhang W, Su LP, Liu LH, Gao YH, Wang QS, Su H, Song YQ, Zhang HL, Shen J, Jing HM, Wang SY, Cen XN, Liu H, Liu AC, Li ZJ, Luo JM, He JX, Wang JW, O'Connor OA, Zhou DB. Wang W, et al. Among authors: cen xn. Ann Hematol. 2024 May 28. doi: 10.1007/s00277-024-05708-w. Online ahead of print. Ann Hematol. 2024. PMID: 38805037
516 results